Literature DB >> 22356305

Validation of the isolation and quantification of kidney enriched miRNAs for use as biomarkers.

Jack W Sharkey1, Daniel J Antoine, B Kevin Park.   

Abstract

CONTEXT: MiRNAs have been reported to represent sensitive and translational biomarkers of organ injury.
OBJECTIVE: To validate the methodologies for the isolation and quantification of a miRNAs from none-invasive biofluids.
METHODS: Commercially available miRNA isolation kits and qPCR was utilised for determination of analyte sensitivity, stability, recovery, and precision.
RESULTS: qPCR was highly precise and sensitive for endogenous miRNA quantification (miR-194, LLQ; 0.1 pM). Intra and inter-assay variation remained low (<12%). Variable recovery (54-89%) was controlled for by internal synthetic standards (C. elegans Lin-4).
CONCLUSIONS: Translational endogenous miRNAs reflective of renal injury represent stable analytes with a large dynamic range that can be quantified easily in most laboratories.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356305     DOI: 10.3109/1354750X.2012.657246

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  14 in total

1.  Circulating levels of miR-122 increase post-mortem, particularly following lethal dosing with pentobarbital sodium: implications for pre-clinical liver injury studies.

Authors:  Joanna I Clarke; Shiva Seyed Forootan; Jonathan D Lea; Lawrence S Howell; Josep Monne Rodriguez; Anja Kipar; Christopher E Goldring; B Kevin Park; Ian M Copple; Daniel J Antoine
Journal:  Toxicol Res (Camb)       Date:  2017-04-11       Impact factor: 3.524

2.  miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export.

Authors:  Matthew B Hudson; Myra E Woodworth-Hobbs; Bin Zheng; Jill A Rahnert; Mitsi A Blount; Jennifer L Gooch; Charles D Searles; S Russ Price
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

Review 3.  The emerging role of extracellular vesicles as biomarkers for urogenital cancers.

Authors:  Muhammad Nawaz; Giovanni Camussi; Hadi Valadi; Irina Nazarenko; Karin Ekström; Xiaoqin Wang; Simona Principe; Neelam Shah; Naeem M Ashraf; Farah Fatima; Luciano Neder; Thomas Kislinger
Journal:  Nat Rev Urol       Date:  2014-11-18       Impact factor: 14.432

Review 4.  Urinary microRNA in kidney disease: utility and roles.

Authors:  In O Sun; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-13

5.  miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle.

Authors:  Matthew B Hudson; Jill A Rahnert; Bin Zheng; Myra E Woodworth-Hobbs; Harold A Franch; S Russ Price
Journal:  Am J Physiol Cell Physiol       Date:  2014-05-28       Impact factor: 4.249

6.  Determination of reference microRNAs for relative quantification in porcine tissues.

Authors:  Oriol Timoneda; Ingrid Balcells; Sarai Córdoba; Anna Castelló; Armand Sánchez
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

7.  Isolation and quantification of microRNAs from urinary exosomes/microvesicles for biomarker discovery.

Authors:  Lin-Li Lv; Yuhan Cao; Dan Liu; Min Xu; Hong Liu; Ri-Ning Tang; Kun-Ling Ma; Bi-Cheng Liu
Journal:  Int J Biol Sci       Date:  2013-10-12       Impact factor: 6.580

Review 8.  Clinical Application of Human Urinary Extracellular Vesicles in Kidney and Urologic Diseases.

Authors:  Giuseppe De Palma; Fabio Sallustio; Francesco Paolo Schena
Journal:  Int J Mol Sci       Date:  2016-06-30       Impact factor: 5.923

9.  MicroRNA Transcriptome of Poly I:C-Stimulated Peripheral Blood Mononuclear Cells Reveals Evidence for MicroRNAs in Regulating Host Response to RNA Viruses in Pigs.

Authors:  Jiying Wang; Yanping Wang; Haifei Wang; Jianfeng Guo; Huaizhong Wang; Ying Wu; Jianfeng Liu
Journal:  Int J Mol Sci       Date:  2016-09-22       Impact factor: 5.923

Review 10.  MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.

Authors:  Kate Simpson; Alexa Wonnacott; Donald J Fraser; Timothy Bowen
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.